Probabilistic Temporal Prediction of Continuous Disease Trajectories and Treatment Effects Using Neural SDEs

• URL: http://arxiv.org/abs/2406.12807v1
• Date: Tue, 18 Jun 2024 17:22:55 GMT
• Title: Probabilistic Temporal Prediction of Continuous Disease Trajectories and Treatment Effects Using Neural SDEs
• Authors: Joshua Durso-Finley, Berardino Barile, Jean-Pierre Falet, Douglas L. Arnold, Nick Pawlowski, Tal Arbel,
• Abstract summary: We present the first causal temporal framework to model the continuous temporal evolution of disease progression via Neural Differential Equations (NSDE) Our results present the first successful uncertainty-based causal Deep Learning (DL) model to accurately predict future patient MS disability (e.g. EDSS) and treatment effects.
• Score: 6.5527554277858275
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Personalized medicine based on medical images, including predicting future individualized clinical disease progression and treatment response, would have an enormous impact on healthcare and drug development, particularly for diseases (e.g. multiple sclerosis (MS)) with long term, complex, heterogeneous evolutions and no cure. In this work, we present the first stochastic causal temporal framework to model the continuous temporal evolution of disease progression via Neural Stochastic Differential Equations (NSDE). The proposed causal inference model takes as input the patient's high dimensional images (MRI) and tabular data, and predicts both factual and counterfactual progression trajectories on different treatments in latent space. The NSDE permits the estimation of high-confidence personalized trajectories and treatment effects. Extensive experiments were performed on a large, multi-centre, proprietary dataset of patient 3D MRI and clinical data acquired during several randomized clinical trials for MS treatments. Our results present the first successful uncertainty-based causal Deep Learning (DL) model to: (a) accurately predict future patient MS disability evolution (e.g. EDSS) and treatment effects leveraging baseline MRI, and (b) permit the discovery of subgroups of patients for which the model has high confidence in their response to treatment even in clinical trials which did not reach their clinical endpoints.

Related papers

• Deep State-Space Generative Model For Correlated Time-to-Event Predictions [54.3637600983898]
  We propose a deep latent state-space generative model to capture the interactions among different types of correlated clinical events. Our method also uncovers meaningful insights about the latent correlations among mortality and different types of organ failures.
  arXiv  Detail & Related papers  (2024-07-28T02:42:36Z)
• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• Predicting multiple sclerosis disease severity with multimodal deep neural networks [10.599189568556508]
  We describe a pilot effort to leverage structured EHR data, neuroimaging data and clinical notes to build a multi-modal deep learning framework to predict patient's MS disease severity. The proposed pipeline demonstrates up to 25% increase in terms of the area under the Area Under the Receiver Operating Characteristic curve (AUROC) compared to models using single-modal data.
  arXiv  Detail & Related papers  (2023-04-08T16:23:18Z)
• Disability prediction in multiple sclerosis using performance outcome measures and demographic data [8.85999610143128]
  We use multi-dimensional, affordable, physical and smartphone-based performance outcome measures (POM) in conjunction with demographic data to predict disease progression. To the best of our knowledge, our results are the first to show that it is possible to predict disease progression using POMs and demographic data.
  arXiv  Detail & Related papers  (2022-04-08T09:57:00Z)
• Personalized Prediction of Future Lesion Activity and Treatment Effect in Multiple Sclerosis from Baseline MRI [0.34998703934432673]
  Our model is validated on a proprietary dataset of 1817 multi-sequence MRIs acquired from MS patients. Our framework achieves high average precision in the binarized regression of future NE-T2 lesions on five different treatments.
  arXiv  Detail & Related papers  (2022-04-01T18:18:12Z)
• Disentangled Counterfactual Recurrent Networks for Treatment Effect Inference over Time [71.30985926640659]
  We introduce the Disentangled Counterfactual Recurrent Network (DCRN), a sequence-to-sequence architecture that estimates treatment outcomes over time. With an architecture that is completely inspired by the causal structure of treatment influence over time, we advance forecast accuracy and disease understanding. We demonstrate that DCRN outperforms current state-of-the-art methods in forecasting treatment responses, on both real and simulated data.
  arXiv  Detail & Related papers  (2021-12-07T16:40:28Z)
• Longitudinal modeling of MS patient trajectories improves predictions of disability progression [2.117653457384462]
  This work addresses the task of optimally extracting information from longitudinal patient data in the real-world setting. We show that with machine learning methods suited for patient trajectories modeling, we can predict disability progression of patients in a two-year horizon. Compared to the models available in the literature, this work uses the most complete patient history for MS disease progression prediction.
  arXiv  Detail & Related papers  (2020-11-09T20:48:00Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)
• Trajectories, bifurcations and pseudotime in large clinical datasets: applications to myocardial infarction and diabetes data [94.37521840642141]
  We suggest a semi-supervised methodology for the analysis of large clinical datasets, characterized by mixed data types and missing values. The methodology is based on application of elastic principal graphs which can address simultaneously the tasks of dimensionality reduction, data visualization, clustering, feature selection and quantifying the geodesic distances (pseudotime) in partially ordered sequences of observations.
  arXiv  Detail & Related papers  (2020-07-07T21:04:55Z)
• Deep Recurrent Model for Individualized Prediction of Alzheimer's Disease Progression [4.034948808542701]
  Alzheimer's disease (AD) is one of the major causes of dementia and is characterized by slow progression over several years. We propose a novel computational framework that can predict the phenotypic measurements of MRI biomarkers and trajectories of clinical status.
  arXiv  Detail & Related papers  (2020-05-06T08:08:00Z)
• Learning Dynamic and Personalized Comorbidity Networks from Event Data using Deep Diffusion Processes [102.02672176520382]
  Comorbid diseases co-occur and progress via complex temporal patterns that vary among individuals. In electronic health records we can observe the different diseases a patient has, but can only infer the temporal relationship between each co-morbid condition. We develop deep diffusion processes to model "dynamic comorbidity networks"
  arXiv  Detail & Related papers  (2020-01-08T15:47:08Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.